On September 20, Yang Sheng, deputy director of the State Drug Administration, stated at the press conference of the State Information Office that it will support the large-scale, intensive and high-end development of the pharmaceutical industry. Pharmaceutical companies are encouraged to build smart factories and green factories, and will continue to support the development of regional pharmaceutical industries such as the Beijing-Tianjin-Hebei, Yangtze River Delta, Guangdong-Hong Kong-Macao Greater Bay Area, and the Chengdu-Chongqing Shuangcheng Economic Zone, and focus on cultivating 3-5 biomedical industry innovation hubs with international competitiveness. It will support the expansion of open cooperation in the pharmaceutical field, encourage foreign investment to introduce original drugs and high-end medical equipment into domestic production, and encourage Chinese enterprises to go out and develop, so that Chinese pharmaceutical devices can benefit the whole world.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.